Evidence map›Paper›PMID 34821978›Full record

Trial reportClinical oral investigations2022

Effects of different remineralization agents on MIH defects: a randomized clinical study.

Irem Can Olgen, Hayriye Sonmez, Tugba Bezgin

2 registry-linked trialsAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06330272 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Accuracy of Spectrophotometry in Determining the Mineralization of Molar-incisor Hypomineralization Lesions by CPP-ACPF Dental Mousse: Clinical Study

TypeinterventionalSponsorMeire Coelho FerreiraRan2025 to 2026Enrolled98ConditionsMolar Incisor HypomineralizationArmsApplication of dental mousse based on CPP-ACPF
NCT07653373 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

The Effect Of Deproteinization On The Performance Of CPP-ACPF On Hypomineralized Enamel: A Clinical Evaluation

TypeinterventionalSponsorUniversidade CeumaRan2026 to 2028Enrolled54ConditionsMolar Incisor HypomineralizationArmsSodium hypochlorite 5.25%, CPP-ACPF
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Evidence mapping and quality assessment of randomised trials related to molar incisor hypomineralisation.European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2025
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Does the scientific literature provide sufficient information on incisors affected by molar incisor hypomineralisation?European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Irem Can OlgenDepartment of Pediatric Dentistry, Faculty of Dentistry, Ankara University, Ankara, Turkey.
Hayriye SonmezDepartment of Pediatric Dentistry, Faculty of Dentistry, Ankara University, Ankara, Turkey.
Tugba BezginDepartment of Pediatric Dentistry, Faculty of Dentistry, Ankara University, Ankara, Turkey. cetintugba@yahoo.com.ORCID http://orcid.org/0000-0002-3025-308X
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to present a comparative evaluation of the long-term efficacy of fluoride varnish and pastes containing CPP-ACP and CPP-ACP with fluoride (CPP-ACFP) in the remineralization of creamy-white and yellow-brown defects in permanent first molars with MIH. MATERIALS AND

methodsThe study included 120 teeth with yellow-brown or creamy-white defects in 67 children (37 girls, 30 boys) aged 6-9 years (mean, 7.2) who were newly diagnosed with MIH with no substance loss or caries or prior restorative treatment. The patients were randomly divided into the experiment groups; control (oral hygiene motivation only), fluoride varnish, and pastes containing CPP-ACP and CPP-ACPF, and followed up for 24 months. The evaluations were made based on the ICDAS criteria and the measurements which were performed using the laser fluorescence method (DIAGNOdent, KaVo, Biberach, Germany) in the follow-ups.

resultsThe research was completed with 49 patients (23 females, 26 males; mean age, 7.7) and 90 teeth. All remineralization agents increased remineralization rates in both creamy-white and yellow-brown colored defects without presenting any statistically significant difference at the end of the follow-up period (p > 0.05). However, the effects of fluoride varnishes were late to observe when compared to pastes containing CPP-ACP and CPP-ACPF.

conclusionsPastes containing calcium and phosphate may be recommended for the longer-term preservation of teeth with yellow-brown defects which showed a post-eruptive breakdown in a shorter time. CLINICAL RELEVANCE: There is a lack of studies investigating MIH treatments in which lesion appearance was recorded. This study evaluated creamy-white and yellow-brown MIH defects separately and reported long-term results of different remineralization agents.

Indexed as

Dental CariesTooth RemineralizationCaseinsChildFemaleFluoridesFluorides, TopicalHumansMaleMolarCaseinsFluoridesFluorides, TopicalCPP-ACPFluorideLaser fluorescenceMolar incisor hypomineralizationRemineralization

Identifiers

PMID34821978
OpenAlexW3216343266

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.